ARCOMA.ST
Price:
$7.16
Market Cap:
$102.45M
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.
Industry
Medical - Devices
IPO Date
2014-11-14
Stock Exchange
STO
Ticker
ARCOMA.ST
According to Arcoma AB’s latest financial reports and current stock price. The company's current PE Ratio is 15.57. This represents a change of -99.21% compared to the average of 1.96K of the last 4 quarters.
The mean historical PE Ratio of Arcoma AB over the last ten years is 19.44. The current 15.57 PE Ratio has changed 7.91% with respect to the historical average. Over the past ten years (40 quarters), ARCOMA.ST's PE Ratio was at its highest in in the June 2025 quarter at 7.76K. The PE Ratio was at its lowest in in the December 2018 quarter at -58.97.
Average
19.44
Median
4.67
Minimum
-107.23
Maximum
205.15
Discovering the peaks and valleys of Arcoma AB PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.07%
Maximum Annual PE Ratio = 205.15
Minimum Annual Increase = -334.31%
Minimum Annual PE Ratio = -107.23
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 12.68 | -68.99% |
| 2023 | 40.88 | -22.50% |
| 2022 | 52.75 | -334.31% |
| 2021 | -22.51 | -110.97% |
| 2020 | 205.15 | 441.62% |
| 2019 | 37.88 | -135.32% |
| 2018 | -107.23 | 1.07% |
| 2017 | -9.13 | 172.55% |
| 2016 | -3.35 | -73.72% |
| 2015 | -12.74 | -102.01% |
The current PE Ratio of Arcoma AB (ARCOMA.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
35.44
5-year avg
57.79
10-year avg
19.44
Arcoma AB’s PE Ratio is greater than SciBase Holding AB (publ) (-1.59), greater than Biosergen AB (-3.16), greater than Iconovo AB (publ) (-1.48), greater than Luxbright AB (publ) (-2.91), greater than Neola Medical AB (publ) (-7.87), greater than Nanologica AB (publ) (-1.34), greater than Vivesto AB (-0.18), greater than Biovica International AB (publ) (-0.41), greater than SpectraCure AB (publ) (-1.31), greater than BrainCool AB (publ) (-3.64),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.59 | $151.84M | |
| -3.16 | $101.44M | |
| -1.48 | $61.02M | |
| -2.91 | $65.29M | |
| -7.87 | $86.52M | |
| -1.34 | $63.45M | |
| -0.18 | $71.88M | |
| -0.41 | $72.16M | |
| -1.31 | $69.56M | |
| -3.64 | $147.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcoma AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arcoma AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Arcoma AB's PE Ratio?
How is the PE Ratio calculated for Arcoma AB (ARCOMA.ST)?
What is the highest PE Ratio for Arcoma AB (ARCOMA.ST)?
What is the 3-year average PE Ratio for Arcoma AB (ARCOMA.ST)?
What is the 5-year average PE Ratio for Arcoma AB (ARCOMA.ST)?
How does the current PE Ratio for Arcoma AB (ARCOMA.ST) compare to its historical average?